Page last updated: 2024-09-05

opc 28326 and Left Ventricular Dysfunction

opc 28326 has been researched along with Left Ventricular Dysfunction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, H; Fujiwara, T; Goto, K; Hashimoto, A; Kanamori, H; Kawasaki, M; Minatoguchi, S; Miyakoda, G; Nagashima, K; Nakagawa, M; Ogino, A; Okada, H; Takemura, G; Tsujimoto, A; Yabuuchi, Y1

Other Studies

1 other study(ies) available for opc 28326 and Left Ventricular Dysfunction

ArticleYear
OPC-28326, a selective peripheral vasodilator with angiogenic activity, mitigates postinfarction cardiac remodeling.
    American journal of physiology. Heart and circulatory physiology, 2015, Jul-01, Volume: 309, Issue:1

    Topics: Angiogenesis Inducing Agents; Aniline Compounds; Animals; Cell Proliferation; Heart; Ki-67 Antigen; Mice; Myocardial Infarction; Myocardium; Myofibroblasts; Nitric Oxide Synthase Type III; Piperidines; Proto-Oncogene Proteins c-akt; Survival Rate; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling

2015